Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Plos One|June 23, 2011
The retrograde IFT machinery of C. elegans cilia: two IFT dynein complexes?Limin Hao, Evgeni Efimenko, Peter Swoboda, et al.
JACC. Basic to Translational Science|August 16, 2025
Preclinical Efficacy of a Hemostatic Agent in Overcoming Dual Antiplatelet TherapyEvgeni Efimenko, Hairu Zhao, Keith Moskowitz, et al.
Developmental Biology|June 18, 2013
The transcription factor GATA4 is required for follicular development and normal ovarian functionEvgeni Efimenko, Maria B Padua, Nikolay L Manuylov, et al.
Genome Biology|September 19, 2007
Identification of novel regulatory factor X (RFX) target genes by comparative genomics in Drosophila speciesAnne Laurençon, Raphaëlle Dubruille, Evgeni Efimenko, et al.
Development (Cambridge, England)|March 26, 2005
Analysis of xbx genes in C. elegansEvgeni Efimenko, Kerry Bubb, Ho Yi Mak, et al.
Molecular Biology of the Cell|September 8, 2006
Caenorhabditis elegans DYF-2, an orthologue of human WDR19, is a component of the intraflagellar transport machinery in sensory ciliaEvgeni Efimenko, Oliver E Blacque, Guangshuo Ou, et al.
Developmental Biology|July 12, 2011
Transcriptional profiling of C. elegans DAF-19 uncovers a ciliary base-associated protein and a CDK/CCRK/LF2p-related kinase required for intraflagellar transportPrasad Phirke, Evgeni Efimenko, Swetha Mohan, et al.
Plos Genetics|March 29, 2008
An essential role for DYF-11/MIP-T3 in assembling functional intraflagellar transport complexesChunmei Li, Peter N Inglis, Carmen C Leitch, et al.
Cancer Cell|April 21, 2012
Targeting nonclassical oncogenes for therapy in T-ALLPrem S Subramaniam, Dosh W Whye, Evgeni Efimenko, et al.
Molecular Cancer Therapeutics|July 19, 2017
PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease SignatureEvgeni Efimenko, Utpal P Davé, Irina V Lebedeva, et al.
Pageof 2